Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2021 Filed Jun 16, 2021 20:28 UTC |
snyderman nancy lynn MDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020046 · form4.xml · derivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:26 UTC |
GAYNOR RICHARDDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020043 · form4.xml · derivative · entry 2 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:26 UTC |
GAYNOR RICHARDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020043 · form4.xml · derivative · entry 1 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:22 UTC |
Daglio David Angelo Jr.Director
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020038 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:22 UTC |
Daglio David Angelo Jr.Director
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020038 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:21 UTC |
Cooke ShaneDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020037 · form4.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:21 UTC |
Cooke ShaneDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020037 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:37 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001127602-21-019722 · form4.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2022-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:37 UTC |
DIXON WENDY LDirector
|
SaleOrdinary Shares | 25,000 | $25.00 | $625,000.00 |
DisclosureSEC source: 0001127602-21-019722 · form4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,300 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:37 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 25,000 | $18.21 | $455,250.00 |
DisclosureSEC source: 0001127602-21-019722 · form4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:38 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-21-019723 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Ordinary Shares · 13,500 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:38 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 13,500 | $25.00 | $337,500.00 |
DisclosureSEC source: 0001127602-21-019723 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,597 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:38 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 13,500 | $16.55 | $223,425.00 |
DisclosureSEC source: 0001127602-21-019723 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Alva Emily PetersonDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 22,759 | $0.00 Strike: $24.70 | $0.00 |
DisclosureSEC source: 0001127602-21-019720 · form4.xml · derivative · entry 4 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,759 Underlying: Ordinary Shares · 22,759 shares Expires 2031-06-09 F5 · derivative.exercise_date: Shares subject to the stock option award vest in three annual installments commencing on 6/9/2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Alva Emily PetersonDirector
|
GrantRestricted Stock Unit Award · Derivative | 11,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-019720 · form4.xml · derivative · entry 3 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,387 Underlying: Ordinary Shares · 11,387 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 6/9/2022. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 6/9/2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Alva Emily PetersonDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 1,115 | $0.00 Strike: $24.70 | $0.00 |
DisclosureSEC source: 0001127602-21-019720 · form4.xml · derivative · entry 2 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Underlying: Ordinary Shares · 1,115 shares Expires 2031-06-09 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/9/2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Alva Emily PetersonDirector
|
GrantRestricted Stock Unit Award · Derivative | 532 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-019720 · form4.xml · derivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532 Underlying: Ordinary Shares · 532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/9/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/9/2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:36 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 882 | $24.60 | $21,697.20 |
DisclosureSEC source: 0001127602-21-019721 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:44 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-21-019456 · form4.xml · derivative · entry 3 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:44 UTC |
ANSTICE DAVID WDirector
|
SaleOrdinary Shares | 5,000 | $24.00 | $120,000.00 |
DisclosureSEC source: 0001127602-21-019456 · form4.xml · nonDerivative · entry 2 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,081 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:44 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionOrdinary Shares | 5,000 | $14.60 | $73,000.00 |
DisclosureSEC source: 0001127602-21-019456 · form4.xml · nonDerivative · entry 1 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:51 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 1,250 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-21-019458 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:51 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 368 | $23.50 | $8,648.00 |
DisclosureSEC source: 0001127602-21-019458 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 882 Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:51 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-019458 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:50 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-21-019457 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Ordinary Shares · 13,500 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:50 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 13,500 | $24.00 | $324,000.00 |
DisclosureSEC source: 0001127602-21-019457 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,597 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:50 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 13,500 | $16.55 | $223,425.00 |
DisclosureSEC source: 0001127602-21-019457 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 22:41 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-21-019455 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Ordinary Shares · 3,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 6/5/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 6/5/2020. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 22:41 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 1,029 | $23.08 | $23,749.32 |
DisclosureSEC source: 0001127602-21-019455 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,474 Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 22:41 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 3,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-019455 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:32 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017782 · form4.xml · derivative · entry 3 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:32 UTC |
ANSTICE DAVID WDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017782 · form4.xml · nonDerivative · entry 2 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,081 Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:32 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017782 · form4.xml · nonDerivative · entry 1 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC |
Wilson Frank AndersDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:41 UTC |
Wysenski NancyDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017792 · form4.xml · derivative · entry 4 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F2 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:41 UTC |
Wysenski NancyDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017792 · form4.xml · nonDerivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:41 UTC |
Wysenski NancyDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017792 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:33 UTC |
BREYER ROBERT ADirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017784 · form4.xml · derivative · entry 3 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:33 UTC |
BREYER ROBERT ADirector
|
Tax withholdingOrdinary Shares | 2,930 | $21.92 | $64,225.60 |
DisclosureSEC source: 0001127602-21-017784 · form4.xml · nonDerivative · entry 2 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,330 Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:33 UTC |
BREYER ROBERT ADirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017784 · form4.xml · nonDerivative · entry 1 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:37 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017789 · form4.xml · derivative · entry 4 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F2 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:37 UTC |
MITCHELL PAUL JDirector
|
Tax withholdingOrdinary Shares | 2,930 | $21.92 | $64,225.60 |
DisclosureSEC source: 0001127602-21-017789 · form4.xml · nonDerivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,174 Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:37 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017789 · form4.xml · nonDerivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:34 UTC |
DIXON WENDY LDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017786 · form4.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:34 UTC |
DIXON WENDY LDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017786 · form4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,300 Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:34 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017786 · form4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:38 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017790 · form4.xml · derivative · entry 3 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:38 UTC |
snyderman nancy lynn MDDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017790 · form4.xml · nonDerivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.